Annual EBIT
-$256.78 M
+$367.00 K+0.14%
31 December 2023
Summary:
REGENXBIO annual earnings before interest & taxes is currently -$256.78 million, with the most recent change of +$367.00 thousand (+0.14%) on 31 December 2023. During the last 3 years, it has fallen by -$151.54 million (-144.00%). RGNX annual EBIT is now -253.28% below its all-time high of $177.09 million.RGNX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$58.78 M
-$6.24 M-11.87%
30 September 2024
Summary:
REGENXBIO quarterly earnings before interest & taxes is currently -$58.78 million, with the most recent change of -$6.24 million (-11.87%) on 30 September 2024. Over the past year, it has increased by +$1.47 million (+2.44%). RGNX quarterly EBIT is now -118.72% below its all-time high of $313.93 million, reached on 31 December 2021.RGNX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$234.35 M
+$1.47 M+0.62%
30 September 2024
Summary:
REGENXBIO TTM earnings before interest & taxes is currently -$234.35 million, with the most recent change of +$1.47 million (+0.62%) on 30 September 2024. Over the past year, it has increased by +$16.42 million (+6.55%). RGNX TTM EBIT is now -239.89% below its all-time high of $167.52 million, reached on 31 December 2021.RGNX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.1% | +2.4% | +6.5% |
| 3 y3 years | -144.0% | -13.7% | -25.9% |
| 5 y5 years | -346.6% | -63.7% | -159.8% |
RGNX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -253.3% | +0.1% | -118.7% | +17.1% | -239.9% | +9.9% |
| 5 y | 5 years | -253.3% | +0.1% | -118.7% | +17.1% | -239.9% | +9.9% |
| alltime | all time | -253.3% | +0.1% | -118.7% | +17.1% | -239.9% | +9.9% |
REGENXBIO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$58.78 M(+11.9%) | -$234.35 M(-0.6%) |
| June 2024 | - | -$52.54 M(-14.4%) | -$235.82 M(-7.2%) |
| Mar 2024 | - | -$61.36 M(-0.5%) | -$254.22 M(-1.0%) |
| Dec 2023 | -$256.78 M(-0.1%) | -$61.68 M(+2.4%) | -$256.78 M(+2.4%) |
| Sept 2023 | - | -$60.24 M(-15.1%) | -$250.77 M(-3.6%) |
| June 2023 | - | -$70.94 M(+11.0%) | -$260.06 M(+3.8%) |
| Mar 2023 | - | -$63.92 M(+14.8%) | -$250.44 M(-2.6%) |
| Dec 2022 | -$257.15 M(-253.5%) | -$55.67 M(-19.9%) | -$257.15 M(-328.7%) |
| Sept 2022 | - | -$69.53 M(+13.4%) | $112.44 M(-13.7%) |
| June 2022 | - | -$61.32 M(-13.2%) | $130.28 M(-7.2%) |
| Mar 2022 | - | -$70.63 M(-122.5%) | $140.32 M(-16.2%) |
| Dec 2021 | $167.52 M(-259.2%) | $313.93 M(-707.3%) | $167.52 M(-190.0%) |
| Sept 2021 | - | -$51.70 M(+0.8%) | -$186.13 M(+48.1%) |
| June 2021 | - | -$51.27 M(+18.1%) | -$125.64 M(+15.7%) |
| Mar 2021 | - | -$43.43 M(+9.3%) | -$108.63 M(+3.2%) |
| Dec 2020 | -$105.24 M(+8.0%) | -$39.73 M(-552.1%) | -$105.24 M(+93.7%) |
| Sept 2020 | - | $8.79 M(-125.6%) | -$54.33 M(-45.1%) |
| June 2020 | - | -$34.26 M(-14.4%) | -$99.01 M(-2.6%) |
| Mar 2020 | - | -$40.04 M(-457.9%) | -$101.62 M(+4.2%) |
| Dec 2019 | -$97.49 M | $11.19 M(-131.2%) | -$97.49 M(+8.1%) |
| Sept 2019 | - | -$35.90 M(-2.6%) | -$90.21 M(+17.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$36.87 M(+2.7%) | -$77.04 M(+127.8%) |
| Mar 2019 | - | -$35.91 M(-294.4%) | -$33.81 M(-132.5%) |
| Dec 2018 | $104.12 M(-237.2%) | $18.47 M(-181.3%) | $104.12 M(+50.8%) |
| Sept 2018 | - | -$22.73 M(-457.9%) | $69.05 M(-2.0%) |
| June 2018 | - | $6.35 M(-93.8%) | $70.47 M(+43.6%) |
| Mar 2018 | - | $102.03 M(-714.7%) | $49.06 M(-164.7%) |
| Dec 2017 | -$75.89 M(+16.1%) | -$16.60 M(-22.1%) | -$75.89 M(-4.9%) |
| Sept 2017 | - | -$21.31 M(+41.5%) | -$79.76 M(+3.4%) |
| June 2017 | - | -$15.06 M(-34.3%) | -$77.11 M(+0.1%) |
| Mar 2017 | - | -$22.92 M(+12.0%) | -$77.01 M(+17.9%) |
| Dec 2016 | -$65.34 M(+186.7%) | -$20.47 M(+9.6%) | -$65.34 M(+30.6%) |
| Sept 2016 | - | -$18.67 M(+24.9%) | -$50.05 M(+29.2%) |
| June 2016 | - | -$14.95 M(+32.9%) | -$38.73 M(+28.8%) |
| Mar 2016 | - | -$11.25 M(+117.4%) | -$30.06 M(+31.8%) |
| Dec 2015 | -$22.79 M(+519.0%) | -$5.18 M(-29.5%) | -$22.80 M(+14.9%) |
| Sept 2015 | - | -$7.35 M(+16.8%) | -$19.84 M(+39.8%) |
| June 2015 | - | -$6.29 M(+57.6%) | -$14.20 M(+79.5%) |
| Mar 2015 | - | -$3.99 M(+80.0%) | -$7.91 M(+101.9%) |
| Dec 2014 | -$3.68 M(-22.9%) | -$2.22 M(+30.3%) | -$3.92 M(+130.3%) |
| Sept 2014 | - | -$1.70 M | -$1.70 M |
| Dec 2013 | -$4.78 M | - | - |
FAQ
- What is REGENXBIO annual earnings before interest & taxes?
- What is the all time high annual EBIT for REGENXBIO?
- What is REGENXBIO annual EBIT year-on-year change?
- What is REGENXBIO quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for REGENXBIO?
- What is REGENXBIO quarterly EBIT year-on-year change?
- What is REGENXBIO TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for REGENXBIO?
- What is REGENXBIO TTM EBIT year-on-year change?
What is REGENXBIO annual earnings before interest & taxes?
The current annual EBIT of RGNX is -$256.78 M
What is the all time high annual EBIT for REGENXBIO?
REGENXBIO all-time high annual earnings before interest & taxes is $177.09 M
What is REGENXBIO annual EBIT year-on-year change?
Over the past year, RGNX annual earnings before interest & taxes has changed by +$367.00 K (+0.14%)
What is REGENXBIO quarterly earnings before interest & taxes?
The current quarterly EBIT of RGNX is -$58.78 M
What is the all time high quarterly EBIT for REGENXBIO?
REGENXBIO all-time high quarterly earnings before interest & taxes is $313.93 M
What is REGENXBIO quarterly EBIT year-on-year change?
Over the past year, RGNX quarterly earnings before interest & taxes has changed by +$1.47 M (+2.44%)
What is REGENXBIO TTM earnings before interest & taxes?
The current TTM EBIT of RGNX is -$234.35 M
What is the all time high TTM EBIT for REGENXBIO?
REGENXBIO all-time high TTM earnings before interest & taxes is $167.52 M
What is REGENXBIO TTM EBIT year-on-year change?
Over the past year, RGNX TTM earnings before interest & taxes has changed by +$16.42 M (+6.55%)